Scroll to the top

{{ subpage.title }}

A mother holds her daughter's arm as a healthcare worker administers the child with Pfizer-BNT covid-19 vaccine in Taiwan.

Jui Kun Weng / SOPA Images/Sipa USA via Reuters Connect

COVID vaccine rollout: Taking stock 3 years on

It’s been almost three years since the World Health Organization declared COVID-19 a global pandemic.

Since then, we have gone from the fear of greeting one another in public to the horrors of overcrowded ERs and morgues — to the remarkably fast development of a vaccine and its uneven rollout. Nearly 7 million people have died worldwide, and while the virus is still out there, most countries now have access to effective jabs.

Read moreShow less
After COVID vaccines, time to use mRNA tech against other infectious diseases
After COVID Vaccines, Time to Use mRNA Tech Against Other Infectious Diseases | GZERO Media

After COVID vaccines, time to use mRNA tech against other infectious diseases

Using mRNA technology to develop effective COVID vaccines has been a scientific breakthrough.

But that's just the tip of the iceberg, Melanie Saville, head of vaccine development at the Coalition for Epidemic Preparedness Innovations, said during a livestream discussion on equitable vaccine distribution hosted by GZERO Media in partnership with the Bill & Melinda Gates Foundation. "

There's still a lot that should be done with the technology moving forward" on other infectious diseases like HIV, malaria, or TB. Still, she said that vaccines are only the beginning.

Local manufacturing and distribution is as important — as is future equitable access to the mRNA tech itself.

Subscribe to our free newsletter, GZERO Daily